Site hosted by Angelfire.com: Build your free website today!

Although there are no guarantees for prostate cancer prevention, following the above steps can help you reduce your risk of getting the disease. A healthier lifestyle will also help you prevent other types of cancer and disease, and keep you feeling younger as your body ages.


Even though most doctors promise to provide complete cure, survival rates among patients remains the same. Most methods of treatment cause adverse side effects and it causing the patient to live with life long disabilities.


The cancer tends to develop in males who are over the age of fifty, though many never show symptoms because its progress is slow in most cases, and men with the condition may often die of other causes such as heart disease, pneumonia, other types of cancers or even old age.


A recent Harvard study, among others, found that diets high in lycopene-rich tomatoes, tomato products and other lycopene-rich sources have been shown to be associated with a lowered risk of developing prostate cancer.


One of the most common cancers in men is prostate cancer which affects the prostate - the gland that secretes seminal fluids which aid in transporting sperm. The cancer usually progresses slowly, but there are also some cases of quickly spreading this cancers. Aggressive cancer means the damaged cells have more differences compared to normal cells. In biopsies, doctors grade the aggressiveness of the cancer to identify the proper treatment and the fatality of the disease. Based on the Gleason score, the slowest progressing cancer is graded two and the cancer that spreads the quickest is graded ten. Non-aggressive cancers can be cured by medication only while the aggressive ones may require surgeries and other series of tests and medication. You must also understand that medicines like generic viagra could help in case you have erection troubles. You may check out viagra reviews


Eric J. Small, MD, UCSF professor of medicine and urology, along with other 19 US institutions conducted the study which was funded by the Dendreon Corporation (the developer of the vaccine) based in Seattle, Washington. They tested 31 patients who were suffering of asymptomatic metastatic hormone refractory prostate cancer (HRPC) and had only one year left to live. The study was designed for observing if the disease progression will be delayed and patients will survive longer. In July1, 2006 the Journal of Clinical Oncology published the first conclusions of this research.


Beam therapy is done by placing the patient into a linear accelerator to send beams of radioactive particles firing directly at the prostate. The latest techniques enable the beam to match the shape of the prostate so that other tissue isnt damaged. Usually, beam therapy is done over a period of several weeks daily. There are fewer side effects with newer forms of prostate cancer radiation therapy, however.